成都年轻人脉管炎治疗方法成都治疗腿部血栓{静脉炎},成都急性前列腺肥大治疗需要多少钱,成都专治老烂腿的医院在哪里,成都好精索静脉曲张医院,成都看好大隐静脉曲张费用多少,成都治雷诺氏症价钱,成都治疗血管畸形费用

WASHINGTON (AP) — The United States added 1.8 million jobs in July, a pullback from the gains of May and June and evidence that the resurgent coronavirus is stalling hiring and slowing an economic rebound. With confirmed viral cases still elevated in much of the nation and businesses under continued pressure, many employers appear reluctant or unable to hire. The unemployment rate did decline in July from 11.1% to 10.2%, though that still exceeds the highest rate during the 2008-2009 Great Recession.July’s job gain was much lower than June’s 4.8 million and May’s 2.7 million jobs, both of which were revised slightly.Even counting the hiring of the past three months, the economy has now recovered only about 42% of the 22 million jobs it lost to the pandemic-induced recession, according to the Labor Department’s jobs report released Friday. 858

Watching your dog get old is hard. You see the pain in their eyes when they can't get into the car or run after the ball.Veterinarians across the U.S. say it's not just old age, but arthritis that's causing your dog pain, and a new drug trial is working to make your furry companion feel better.One of the clinics testing the new drug is Paradise Animal Hospital in Catonsville, Maryland. Dr. Cheryl Burke says she to qualify for the trial, dogs have to have obvious signs of arthritis and cannot have cancer. At the clinic, they conduct blood tests, x-rays and a physical exam.Hannah, a blonde chow mix, came in for the procedure."She has a lot of trouble getting up and when she goes to walk up and down the stairs, she stares, like can I do this? Can I do this? Breaks my heart when I see that," Hannah's mom, Donna Foster said.Foster found out from a friend this clinic was conducting the trial and thought she'd take a chance, "I mean she's fourteen years old and basically she's really healthy so if I can keep her for another 20 years, I know that's not realistic but I will and I want her to have a quality of life."The trial was created in San Diego, by Animal Cell Therapies, and uses canine stem cells to grow cartilage in the joint, so the dog has more cushion when he/she walks or runs."Stem cells are the body's primitive precursor cells and we all have them, and when we're born, there's a huge population of them in our umbilical cord," Dr. Burke said.The stem cells adapt to the needs around them, so they could turn cancerous, something Dr. Burke and pet parents don't want. That's why dogs go through several tests (for free) before they can qualify.The clinic is doing the entire trial for free, to get FDA approval, so other pet parents can one day buy the drug.Part of the study requires that the test be double blind, meaning no one, even Dr. Burke can see which drug is given to the dog.Each dog undergoes the same procedure. Then pet parents come back for a one month, three month and six month check up to see how the dog is progressing.If the study is approved any dog who didn't get the drug will get it for free."If it's approved, it could be a few years, before it's on the market but it could be wonderful," Dr. Burke said.There is no ballpark figure as to how much the drug may cost, but dog lovers are hopeful it could help their furry friend have a longer, better life. 2431

Washington state's Supreme Court on Thursday ruled the death penalty was unconstitutional because it was inconsistently applied, making Washington the 20th state in the US to outlaw capital punishment.The court said the death penalty's use varied depending on the location of the crime or the race of the accused -- a violation of the state's constitution. Budgetary resources and county of residence were also contributing factors, the ruling said.The state has eight prisoners on death row, according to the Death Penalty Information Center, and the ruling said all their death sentences would be changed to life in prison."The court makes it perfectly clear that capital punishment in our state has been imposed in an 'arbitrary and racially biased manner,' is 'unequally applied' and serves no criminal justice goal," said Washington Gov. Jay Inslee, who in 2014 imposed a moratorium on the death penalty, saying it was inconsistently applied."This is a hugely important moment in our pursuit for equal and fair application of justice," he added.The state has carried out five executions since the?US Supreme Court reinstated capital punishment in 1976, data from the nonprofit shows. All five defendants were white.But studies have indicated race does play a role in juries' decision to sentence a defendant to death. A study from the University of Washingtonfound jurors in the state were "more than four times more likely to impose a death sentence if the defendant is black."The ruling was handed down Thursday morning in the case of Allen Eugene Gregory, who was convicted and sentenced to death in 2001 for the murder of of a woman five years prior, according to court documents.The court said it would not reconsider Gregory's conviction of aggravated first-degree murder.In a statement, the American Civil Liberties Union praised the court's decision."Washington's Supreme Court showed courage in refusing to allow racism to infect life and death decisions," said Jeff Robinson, the ACLU's deputy legal director and director of the Trone Center for Justice. "Let's hope that courage is contagious." 2153

WASHINGTON, D.C. — Federal officials say the key component to getting the COVID-19 vaccine distributed across the country will lie in the hands of states, with help from major pharmacy chains, like CVS and Walgreens.“We want to replicate what the experience you have with the flu vaccine — convenient to you, a tried-and-true system that we do hundreds of millions of vaccines through every year,” said U.S. Health and Human Services Secretary Alex Azar. “That's the backbone of the approach we're taking.”Yet, if flu vaccine rates are any indication, that backbone may not suffice.Dr. Eric Schneider is with The Commonwealth Fund, an independent organization that studies health policy. They recently delved into previous vaccination rates to see how it might unfold for COVID-19.“Our health care system does well at developing new technologies like these vaccines, which are really quite amazing, scientifically speaking,” Dr. Schneider said. “But we don't do as well at making sure those technologies are distributed to the people who need them most. And we're seeing that in the prior vaccination experience, and I’m worried we will see that with COVID-19.”What did they find?A mere 51% of Americans got the flu vaccine last year and only 38% got the H1N1 swine flu vaccine 10 years ago, which had a similar vaccine development timetable and pressure to COVID-19.Those low vaccination rates matter because in order for the COVID-19 vaccine to create herd immunity in the U.S., between 70 and 90% of all Americans will need to get vaccinated.“The concept of herd immunity really is developed out of vaccination programs because the question is ‘What proportion of the population needs to be vaccinated to prevent the circulation of a virus in the population?’” Dr. Schneider said.Just getting that shot could vary depending on where you live, as the federal government is leaving that up to each state.“That's going to be up to the nation's governors as they prioritize within their states,” HHS Secretary Azar said.However, Dr. Schneider said that in order for the states to pull it off, they are going to need federal help.“States are in incredible difficulty right now with their budgets and they need federal support,” he said. “Congress is considering a federal rescue package. That funding is really necessary to get states the support they need to vaccinate large numbers of people.”Large numbers of people are now waiting for a rescue of their own from a virus that’s changed everything.For a closer look at the results of the study on vaccination rates from The Commonwealth Fund, click here. 2612

WASHINGTON, D.C. – One of the most contentious battles in politics isn’t just the current battle for the White House, it’s also the upcoming battle over who could ultimately end up in the halls of Congress and state capitols everywhere, in a process called redistricting.“The basic idea underlying that system is that we should form a constituency with people who live near us,” said Charles Blahous, a senior research strategist at the Mercatus Center at George Mason University in Virginia.New district maps are created based on census population numbers every 10 years. Yet, those maps can end up getting distorted to favor one political party over another when gerrymandering comes in to play.“I think gerrymandering is of concern to most voters because it seems to violate the foundational principle of our representative system, which is that we are divided into districts geographically,” Blahous said.Geography is something gerrymandering throws out the window. Some of the unusual congressional district maps can end up looking like animals.There is Maryland’s Democratic 3rd district, which looks like a snake, stretching from Baltimore into counties south. There is also northern Ohio’s Republican 4th district, known as “the duck.”So, who designed these?“The Constitution gives the power to state legislatures to draw these maps,” Blahous said.Since politicians draw the maps, they can be skewed to favor a particular party or incumbent. However, they can also be used to favor people from a particular racial or ethnic group, who have often been under-represented in the halls of power, in order to comply with federal Voting Rights Act rules on representation.Still, there are now efforts to take the map drawing out of the hands of politicians.In Virginia, voters will decide this November whether an independent commission should be in charge of the process instead. There are other ideas emerging, too: like using artificial intelligence to make the maps.“It takes an enormous computer capacity, which was not there 30 years ago, and writing the programming to make that all happen is also not a trivial matter,” said political science professor Bruce Cain, director of the Bill Lane Center for the American West at Stanford University.Prof. Cain said he and a colleague, Prof. Wendy Tam Cho of the University of Illinois at Urbana-Champaign, believe an algorithm they’ve developed might be the best alternative for making fairer maps.“What you want to be able to do is take every plan and classify it and say, ‘yeah, this one's better for minorities, this one's better for compactness,’ but is there something that combines both of them?” he said.It is all part of the ongoing effort to make sure America’s representative democracy remains truly representative of the people. 2801